463.82MMarket Cap-0.39P/E (TTM)
23.930High17.840Low126.79KVolume23.640Open23.790Pre Close2.53MTurnover1.45%Turnover RatioLossP/E (Static)25.41MShares41.87052wk High608.33P/B159.68MFloat Cap11.66552wk Low--Dividend TTM8.75MShs Float728.003Historical High--Div YieldTTM25.60%Amplitude11.665Historical Low19.978Avg Price1Lot Size
Cartesian Therapeutics Stock Forum
Cartesian Therapeutics Gets FDA Rare Pediatric Disease Designation for Dermatomyositis Treatment
Dow Jones· just
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Murat Kalayoglu(19.9%),Seven One Eight Three Four Irrevocable Trust(17.1%), etc.
SEC announcement
13 mins ago
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals...
No comment yet